How to Source Non-IMP Supplies for Clinical Trials
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP...
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP...
Chloé Thépaut, MRes, Oncology Senior Analyst, GlobalData, examines the implications of Sandoz’s abandoned attempt to...
Eight months in, Nigel Hughes, Scientific Director JCI-PDR, Janssen, examines the ramifications of GDPR on...
In the latest Industry Viewpoint, Howard Fingert speaks to CTA’s Elizabeth Williams about the challenges...
John Shillingford, Clinical Operations Director, Orsus Medical, describes the inherent challenges facing small- to mid-sized...
Gavin Davidson, CVMD Analyst, GlobalData, examines how MDMA is used to treat patients with PTSD
Hedley Rees, Chief Disruptor, PharmaFlow, discusses the need for a rethink on supply chain processes
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded...
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations...
Barrett Glasser, Associate Director, Clinical Drug Supply, Biogen, provides an overview on how to on...